Clinical Trial Update: Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update from Bayer evaluating efficacy and safety for treating dysfunctional uterine bleeding (metrorrhagia); the study is completed with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dysfunctional Uterine Bleeding
• Metrorrhagia

Snippet

Sponsor: Bayer | Conditions: Metrorrhagia | Phase 3 | Status: COMPLETED | Results posted: 2011-07-29